Announcements Trials

Browse Landscape

Sponsor

Conditions

Breast Neoplasms 14 Neoplasm Metastasis 8 Neoplasms 5 Carcinoma, Non-Small-Cell Lung 4 Stomach Neoplasms 3 Colorectal Neoplasms 3 Adenocarcinoma 3 Brain Neoplasms 2 Triple Negative Breast Neoplasms 1 Meningeal Carcinomatosis 1 HER2-mutant Non-Small Cell Lung Cancer 1 Gastrointestinal Neoplasms 1 Carcinoma, Transitional Cell 1

Interventions

Sunitinib 64 Nivolumab 42 pembrolizumab 36 Bevacizumab 32 Everolimus 31 Sorafenib 25 pazopanib 23 Axitinib 23 cabozantinib 14 aldesleukin 13 Ipilimumab 13 temsirolimus 11 Interferon alpha-2 11 Cyclophosphamide 10 avelumab 9 Magnetic Resonance Spectroscopy 9 Interleukin-2 9 lenvatinib 8 atezolizumab 8 Radiosurgery 8 Gemcitabine 8 Immunoglobulin G 7 Erlotinib Hydrochloride 7 Disulfides 6 fludarabine phosphate 5 Radiotherapy 5 Fluorodeoxyglucose F18 5 peginterferon alfa-2b 4 Vorinostat 4 Tyrosine Kinase Inhibitors 4

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

0 trials

Recent Start date Enrollment

Has results × Carcinoma, Renal Cell × trastuzumab deruxtecan × Clear all

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡